Douglas Goetz, Ph.D.

Faculty researchers from Ohio University’s Heritage College of Osteopathic Medicine and Russ College of Engineering and Technology have received a $100,000 grant to investigate possible treatments for mitigating the severity of COVID-19.

Kelly McCall, Ph.D., and Douglas Goetz, Ph.D., will measure how effective a number of different chemical compounds are at preventing “cytokine storms,” a sometimes-fatal complication that can stem from COVID-19 infections.

The body responds to the presence of a pathogen by releasing a swarm of immune system proteins called cytokines to help fight off the virus or bacterium. If too many cytokines are released, a cytokine storm develops which can severely damage organs. This reaction is believed to be responsible for some of the deaths from COVID-19… Continue reading.

WASHINGTON, D.C. — The American Institute for Medical and Biological Engineering (AIMBE) has announced the induction of Douglas Goetz, Ph.D., Professor, Department of Chemical and Biomolecular Engineering, Ohio University, to its College of Fellows.

Election to the AIMBE College of Fellows is among the highest professional distinctions accorded to a medical and biological engineer. The College of Fellows is comprised of the top two percent of medical and biological engineers. College membership honors those who have made outstanding contributions to “engineering and medicine research, practice, or education” and to “the pioneering of new and developing fields of technology, making major advancements in traditional fields of medical and biological engineering, or developing/implementing innovative approaches to bioengineering education.”

Dr. Goetz was nominated, reviewed, and elected by peers and members of the College of Fellows for “insights into the mechanisms of cellular adhesion, and use of this knowledge to propose and develop novel therapeutics.“